| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.097 | 0.006 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.008 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.078 | 0.01 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.01 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |